ARGX Valuation

argenx SE

Add to Watchlist

Advanced Chart

798.940

+1.59(0.199%)1D

Overview
Forecast
Valuation
Earnings

ARGX Relative Valuation

ARGX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ARGX is overvalued; if below, it's undervalued.

Historical Valuation

argenx SE (ARGX) is now in the Fair zone, suggesting that its current forward PS ratio of 10.45 is considered Fairly compared with the five-year average of -73.85. The fair price of argenx SE (ARGX) is between 491.43 to 3704.83 according to relative valuation methord.

Relative Value

Fair Zone

491.43-3704.83

Current Price：797.35

Fair

38.47

Trailing

Forward

30.74

EV/EBITDA

argenx SE. (ARGX) has a current EV/EBITDA of 30.74. The 5-year average EV/EBITDA is -11.44. The thresholds are as follows: Strongly Undervalued below -217.03, Undervalued between -217.03 and -114.24, Fairly Valued between 91.35 and -114.24, Overvalued between 91.35 and 194.14, and Strongly Overvalued above 194.14. The current Forward EV/EBITDA of 30.74 falls within the Historic Trend Line -Fairly Valued range.

31.72

EV/EBIT

argenx SE. (ARGX) has a current EV/EBIT of 31.72. The 5-year average EV/EBIT is -8.27. The thresholds are as follows: Strongly Undervalued below -215.87, Undervalued between -215.87 and -112.07, Fairly Valued between 95.53 and -112.07, Overvalued between 95.53 and 199.32, and Strongly Overvalued above 199.32. The current Forward EV/EBIT of 31.72 falls within the Historic Trend Line -Fairly Valued range.

10.45

argenx SE. (ARGX) has a current PS of 10.45. The 5-year average PS is 31.31. The thresholds are as follows: Strongly Undervalued below -21.15, Undervalued between -21.15 and 5.08, Fairly Valued between 57.54 and 5.08, Overvalued between 57.54 and 83.76, and Strongly Overvalued above 83.76. The current Forward PS of 10.45 falls within the Historic Trend Line -Fairly Valued range.

37.18

P/OCF

argenx SE. (ARGX) has a current P/OCF of 37.18. The 5-year average P/OCF is -54.05. The thresholds are as follows: Strongly Undervalued below -304.58, Undervalued between -304.58 and -179.31, Fairly Valued between 71.22 and -179.31, Overvalued between 71.22 and 196.48, and Strongly Overvalued above 196.48. The current Forward P/OCF of 37.18 falls within the Historic Trend Line -Fairly Valued range.

33.52

P/FCF

argenx SE. (ARGX) has a current P/FCF of 33.52. The 5-year average P/FCF is -63.95. The thresholds are as follows: Strongly Undervalued below -1965.84, Undervalued between -1965.84 and -1014.90, Fairly Valued between 887.00 and -1014.90, Overvalued between 887.00 and 1837.94, and Strongly Overvalued above 1837.94. The current Forward P/FCF of 33.52 falls within the Historic Trend Line -Fairly Valued range.

argenx SE (ARGX) has a current Price-to-Book (P/B) ratio of 8.00. Compared to its 3-year average P/B ratio of 7.37 , the current P/B ratio is approximately 8.58% higher. Relative to its 5-year average P/B ratio of 6.71, the current P/B ratio is about 19.23% higher. argenx SE (ARGX) has a Forward Free Cash Flow (FCF) yield of approximately 0.82%. Compared to its 3-year average FCF yield of -0.74%, the current FCF yield is approximately -209.53% lower. Relative to its 5-year average FCF yield of -1.15% , the current FCF yield is about -171.17% lower.

8.00

P/B

Median3y

7.37

Median5y

6.71

0.82

FCF Yield

Median3y

-0.74

Median5y

-1.15

Competitors Valuation Multiple

The average P/S ratio for ARGX's competitors is 10.45, providing a benchmark for relative valuation. argenx SE Corp (ARGX) exhibits a P/S ratio of 10.45, which is 0.00% above the industry average. Given its robust revenue growth of 98.60%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Summit Therapeutics Inc

Loss

17.34B

NBIX.O

Neurocrine Biosciences Inc

Loss

16.49%

13.79B

Performance Decomposition

Market capitalization of ARGX increased by 36.00% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 6.09 to 25.87.

The secondary factor is the Revenue Growth, contributed 98.60%to the performance.

Overall, the performance of ARGX in the past 1 year is driven by Margin Expansion. Which is more sustainable.

98.60%

477.64M → 948.59M

Revenue Growth

324.79%

6.09 → 25.87

Margin Expansion

-387.39%

-14.83 → 42.63

P/E Change

36.00%